Eli Lilly & Co. (LLY) Tops Q3 EPS by 30c; Trims Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
Citi continue to see upside to Eli Lilly & Co.'s (LLY) 'already rich' valuation
November 2, 2023 11:11 AM EDTCiti analyst Andrew Baum said in a note Thursday that the Mounjaro beat for Eli Lilly & Co. (NYSE: LLY) goes on after the companys solid third-quarter results, which were boosted by the drug.
Baum reiterated a Buy rating and $675 price... More
Eli Lilly (LLY) falls after cutting full-year profit forecast
November 2, 2023 6:45 AM EDTEli Lilly (NYSE: LLY) shares fell in early Thursday trade after the company lowered its full-year outlook.
Eli Lilly now projects an EPS in the range of $6.50 to $6.70, which fell below the consensus estimate of $6.72.
"Lilly had another strong quarter in Q3... More
